The Danish biobanks swings with precision medicine
Biomarkers, biobanks, ICT management of omics data and precision medicine are among the topics of The International Conference on Perspectives in Precision Medicine in Copenhagen 28 February - 1 March 2018.
Helle Bossen Konradsen is confirmed key note speaker and she will present the set-up and use of the Danish biobanks.
Helle Bossen Konradsen, MD, DSc, is Executive Vice President at Statens Serum Institut. Her main responsibility is serving as Director of the Danish National Biobank (DNB) and the associated research laboratories. Since 2017 she has been director of the Danish National Biobank, which is one of the largest and most advanced biobanks in the world. Associated with the Danish National Biobank is highly advanced laboratories, which performs a broad range of omics analyses as part of important international research within precision medicine. Helle Bossen Konradsen says "Together with the outstanding population registers in Denmark, the Danish National Biobank and the Danish Biobank Register offer unprecedented possibilities for studies within precision medicine for researchers worldwide."
Everyone with an interest in precision medicine, especially in the cross field between pharmaceutical development, user involvement and ICT, are welcome to attend the conference. The conference especially targets SMEs, researchers and anyone else who are looking into new insight and knowledge on personalised medicine, want to discover new business and research opportunities, meet potential partners, expand their network, and be inspired by a world leading pharmaceutical hub in the heart of Copenhagen.